Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management.
Hersh ShroffLisa B VanWagner
Published in: Current hepatology reports (2020)
Achieving improved outcomes in patients with NASH requires that future efforts focus on optimizing methods for CVD screening and designing clinical trials with long-term cardiovascular endpoints in mind.